ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

IOM Report Recommends Solutions to Problem of Medication Errors.

July 28, 2006

NCI Marmoset Colony Available For Research

February 11, 1983

Four More COP Awards Announced

January 9, 1981

FDA seeks support for reorganization of cancer programs, but debate continues.

July 9, 2004

Henderson Heads HHS Preparedness Office; NCI Awards $22M Southern Cohort Study.

November 9, 2001

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011